FROM THE NEWSLETTER EDITOR S DESK
|
|
- Fay White
- 5 years ago
- Views:
Transcription
1 BREAK POINT ISSUE 15 FROM THE NEWSLETTER EDITOR S DESK In this issue, antimicrobial stewardship takes on the perspective in the form of stewardship in the General Practitioner and community setting (see article by Minyon Avent, University of Queensland). New treatments for Clostridium difficile infection have also been in the forefront of recent major Infectious Diseases and Gastroenterology meetings alike (summarized within In the News ). As always suggestions towards improving the Newsletter are very welcome. Sharon Chen ASA Breakpoint Editor
2 BREAKPOINT CONTENTS ASA Subscription... Page 02 In the News... Page 02 Antimicrobial Stewardship in General Practice... Page 03 Antimicrobials Page 11 Proposed Program... Page 12 Meeting Calendar... Page 13 ASA SUBSCRIPTION Payment of ASA Subscription renewals can be performed on-line in the Members Area of the website ( Alternatively subscription renewal forms can be downloaded from the Members Area ( and: Faxed: ed: Posted: Australian Society for Antimicrobials PO Box 8266, Angelo Street, South Perth, Western Australia 6151 ASA Application Membership Forms can be downloaded from the ASA website ( IN THE NEWS New pharmacology treatments for Clostridium difficile infection have we arrived? The results in print form of the MODIFY I and II phase III clinical trials are awaited eagerly with the integrated results of both trials presented at various scientific meetings include ICAAC 2015 and ID weeks Both Bezlotoxumab (human IgG 1 monoclonal antibodies which targets toxin B) and Actoxumab (which targets toxin A) were studied in combination and as a single agent with the primary endpoint being recurrence of C. difficile infection (CDI). Both were given as an addition to standard of care therapy. In brief, Bezlotoxumab, Page 02
3 Issue 15 IN THE NEWS CONT D but not Actoxumab, was identified as conferring benefit compared with placebo. It was also efficacious in key subgroups at risk of CDI. Other drugs with promising potential include Cadazolid (currently completed phase II clinical trials) which demonstrated favourable cure rates and recurrence rates compared with vancomycin, whilst administration of nontoxigenic (NTG) C. difficile spores has been studied for prophylaxis against recurrent CDI. Further Reading: 1. Debast SB et al. Clin Microbiol Infect 2014; 20(Suppl 2): Wilcox M et al. ID week San Diego, CA, Oct 7-11 (available at ID week website) 3. Gerding DN et al, JAMA 2015: 313: Loiue T et al, Antimicrob Agents Chemother 2015; 59: ANTIMICROBIAL STEWARDSHIP IN GENERAL PRACTICE Avent ML 1 The University of Queensland, School of Public Health and UQ Centre for Clinical Research, & Faculty of Medicine + Biomedical Sciences, Herston, Brisbane, Australia Summary Antibiotic resistance inevitably follows antibiotic use. Significantly reducing antibiotic prescribing (the pressure that drives resistance to appear and then persist) results in resistant bacteria to disappear overtime. The vast majority of antibiotics in Australia are prescribed by general practitioners (GPs), and the most common indication is for acute respiratory infections (ARIs). Evidence shows that antibiotics are largely ineffective for the management of ARIs. Thus GPs have the potential to be the most effective health care professionals to address the problem of antibiotic resistance. Since 2008 there has been a steady increase in antibiotic prescriptions in the general practice setting in Australia with Queensland having a higher prescribing rate compared to other states. Continued improvements in prescribing practice and a positive influence on clinician and community beliefs will be essential to reduce antibiotic resistance. There are a number of interventions that are effective, or have shown promise, at decreasing antibiotic prescribing for acute respiratory infections (ARIs) in primary care. Many of these strategies have not been adopted in Australia. Page 03
4 BREAKPOINT ANTIMICROBIAL STEWARDSHIP IN GENERAL PRACTICE CONT D Australia is one of the highest users of antibiotics in the developed world, with around 22 million prescriptions written every year in primary care. The defined daily dose in Australia is nearly 23/1000 population/day compared with less than 15/1000 for Denmark, the Netherlands and Sweden combined (figure 1). 1 General Practitioners (GPs) have the potential to be the most effective health care professionals to address the problem of antibiotic resistance as the majority of antibiotics are prescribed in the general practice setting and antibiotics remain the most common class of medicine prescribed. 1 Continued improvements in prescribing practice and a positive influence on individual and community beliefs are essential to limit the spread of antibiotic resistance. 2 Research shows that up to half of antimicrobials prescribed in Australian hospitals are discordant with guidelines or microbiological results and hence are considered inappropriate, 3 however, little is known about what happens in the primary care setting. Inappropriate use of antimicrobials is thought to contribute to an increased risk of antibiotic-resistant pathogens. 4 Patients with infections caused by antibiotic-resistant organisms have an increased mortality compared with those infected with antibiotic-susceptible organisms. 5, 6 Unfortunately, new antimicrobials are not being developed at a pace that comes anywhere close to meeting the urgent need; therefore, the healthcare system needs to undertake efforts that save one of medicine s most precious and long-standing resources. 7 This was summarised by the World Health Day 2011 slogan Combat antibiotic resistance: no action today, no cure tomorrow. Reducing the inappropriate use of antimicrobials has been shown to improve patient outcomes and reduce adverse consequences of antibiotic use (including antibiotic resistance, toxicity and unnecessary costs). 8 Figure1. Comparison of Australian and European antibiotic use in the community in Page 04
5 Issue 15 ANTIMICROBIAL STEWARDSHIP IN GENERAL PRACTICE CONT D There is a strong link between antibiotic consumption and the rate of antibiotic resistance. 9 In Australia antibiotic resistance in common pathogens causing acute respiratory tract infections (ARIs) has increased over the past 20 years. 10 For example, resistance of Streptococcus pneumoniae to macrolide antibiotics has increased from 8.7% in 1994 to 20.4% in 2007, and this trend is continuing. 11 Prescribers are well placed to convey the importance of informing patients that they are twice as likely to carry resistant bacteria after a course of antibiotics as someone who has not taken them These resistant bacteria can persist for up to 12 months after antibiotic use in primary care; but with no further exposure to antibiotics they will disappear overtime. 14 Therefore we must reduce antibiotic use in primary care in order preserve the miracle of antibiotics. Evidence from general practice demonstrates that patient satisfaction is linked more with good communication than a prescription for an antibiotic. 15 Several studies have demonstrated that GPs trained in communication skills prescribed antibiotics significantly less than GPs without training. 16, 17 The benefits of patients managed by a GP trained in enhanced communication skills can persist for at least 3 years, and do not appear to compromise repeat consultation rate, patient recovery or patient satisfaction Figure 2: Distribution for percent of respiratory tract infection consultations with antibiotics prescribed for adults aged years at 568 UK General Practices 20 Page 05
6 BREAKPOINT ANTIMICROBIAL STEWARDSHIP IN GENERAL PRACTICE CONT D Recently surveys of Antimicrobial Stewardship (AMS) in Australian hospitals have identified areas for improvement: reviewing antimicrobial prescribing with feedback to the prescriber, auditing and training and education in antimicrobial use. In addition, there appears to be a lack of resources to support an AMS programs in some facilities Other barriers were also identified: doctors reluctant to change their prescribing practices; high level of transient and/or seconded staff; lack of leadership to promote AMS; lack of support from senior clinicians as well as insufficient training and education in antimicrobial use provided to clinicians However, little is known about what happens in the primary health care setting in Australia. There are a number of interventions that have shown promise at decreasing antibiotic prescribing for ARIs in primary care. None of these strategies or interventions on their own will greatly improve the use of antibiotics (figure 3). However, used in concert, combinations are likely to enable clinicians and health care systems to implement the strategies that will reduce antimicrobial resistance in the future. 24 In addition, professional colleges and collaborations between industry and professional bodies could be used to promote and increase the uptake of, and compliance with, antimicrobial Figure 3: Overview of strategies to minimize antibiotic use in primary care at each stage of the path from healthy person to antibiotic prescription for acute respiratory infection 24 Page 06
7 Issue 15 ANTIMICROBIAL STEWARDSHIP IN GENERAL PRACTICE CONT D resistance related training and initiatives. For example, in the UK, educational and guidance material has been developed in association with professional bodies and industry alliances to aid and promote the appropriate use of antibiotics in both human and animal health. Examples include: a GP toolkit, Treat Antibiotics Responsibly, Guidance and Education Tool (TARGET), developed by the Antimicrobial Stewardship in Primary Care Collaboration and hosted on the Royal College of General Practitioners website; and a similar initiative, Stemming the Tide of Antibiotic Resistance (STAR), which provides resources for GPs to provide to patients during consultations. Currently in Australia an exciting research project is underway to evaluate the uptake and effectiveness of a number of interventions for the management of ARIs entitled General Practitioner Antimicrobial Stewardship Programme Study (GAPS). This trial is funded by the Department of Health and being conducted by The University of Queensland, Bond University and QUT. The study aims to reduce antibiotic resistance in Australia, by reducing the antibiotic prescribing rates for ARIs. Twenty-eight urban general practices in Queensland (20 in Brisbane and 8 in the Gold Coast) are participating: 14 are intervention practices; their performance in antibiotic prescribing will be compared with 14 control practices. The rate of antimicrobial prescribing will be compared with the preceding year s rates, in the same time period, as an internal control/comparison. Semi-structured interviews will be conducted with the practice staff from the intervention group by the investigators. Questions will be about the acceptability and feasibility of the interventions. In addition, health economic data will be used to estimate the costs of implementing the package and determine cost-effectiveness The interventions include: 1. a delayed prescribing protocol: which is a poster-sized commitment letter that is displayed in the GPs waiting room and/or examination room. Each GPs photograph and signature will be inserted as endorsement on the letters. The posted commitment letter, written at the eighth grade reading level and displayed in English emphasises GP commitment to guidelines, i.e. Therapeutic Guidelines: Antibiotic, for appropriate antibiotic prescribing and explains why antibiotics are not appropriate in many cases. 2. Patient information leaflet: which consists of an information leaflet that will provide more information to the patient about the poster-sized commitment letter in the GPs waiting room and/or examination room. 3. Delayed antibiotic prescribing: the GP can choose to provide the patient with a delayed antibiotic prescription with advice to the patient to only have the prescription filled at a pharmacy after a few days if symptoms are not starting to settle or become more severe. A sticker will be applied to the prescription labelling it as a delayed prescription Page 07
8 BREAKPOINT ANTIMICROBIAL STEWARDSHIP IN GENERAL PRACTICE CONT D 4. Patient Decision Aids: which is a brief summary of evidence for the management of a number of ARI conditions. The decision aids have been developed to assist the patient to make an appropriate decision about their condition in conjunction with the GP. 5. Online communication training package: which is offered in combination with background information on the problem of antimicrobial resistance in primary care and the effectiveness of antibiotics for most commonly presenting ARIs 6. Point of care test C-reactive protein (CRP): which is performed on a finger prick blood sample and the result is available during patient consultation and can, therefore, guide antibiotic use. 7. Infection Control strategies. there are very few data about effective Infection control strategies in the GP setting. Surveillance anterior nasal and throat swabs will be taken from General Practice staff and patients to define rates of transmission in staff and community members attending the GP practice for consultation with non-infectious complaints. This will help define what ICP protocols need to be implemented in GP settings. More information about the project can be obtained from the website References 1 Mc Kenzie D, Rawlins MD, Del Mar C. Antimicrobial stewardship: what s it all about? Australian Prescriber. 2013; 36: Antibiotic resistance: a problem for everyone. NPS news Ingram PR, Seet JM, Budgeon CA, Murray R. Point-prevalence study of inappropriate antibiotic use at a tertiary Australian hospital. Intern Med J. 2012; 42: Gottlieb T, Nimmo GR. Antibiotic resistance is an emerging threat to public health: an urgent call to action at the Antimicrobial Resistance Summit The Medical journal of Australia. 2011; 194: van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus Bacteremia. Clinical microbiology reviews. 2012; 25: Spellberg B, Blaser M, Guidos RJ, Boucher HW, Bradley JS, Eisenstein BI, et al. Combating antimicrobial resistance: policy recommendations to save lives. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011; 52 Suppl 5: S Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, et al. Society s failure to protect a precious resource: antibiotics. Lancet. 2011; 378: Page 08
9 Issue 15 ANTIMICROBIAL STEWARDSHIP IN GENERAL PRACTICE CONT D 8 MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clinical microbiology reviews. 2005; 18: Goossens H, Ferech M, Vander Stichele R, Elseviers M, Group EP. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005; 365: Australian Group on Antimicrobial Resistance (AGAR). AGAR surveys: schedule and overview Barry C, Krause VL, Cook HM, Menzies RI. Invasive pneumococcal disease in Australia 2007 and Commun Dis Intell Q Rep. 2012; 36: E Nasrin D, Collignon PJ, Roberts L, Wilson EJ, Pilotto LS, Douglas RM. Effect of beta lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. BMJ. 2002; 324: Chung A, Perera R, Brueggemann AB, Elamin AE, Harnden A, Mayon-White R, et al. Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ. 2007; 335: Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010; 340: c Welschen I, Kuyvenhoven M, Hoes A, Verheij T. Antibiotics for acute respiratory tract symptoms: patients expectations, GPs management and patient satisfaction. Fam Pract. 2004; 21: Cals JW, Scheppers NA, Hopstaken RM, Hood K, Dinant GJ, Goettsch H, et al. Evidence based management of acute bronchitis; sustained competence of enhanced communication skills acquisition in general practice. Patient education and counseling. 2007; 68: Cals JW, de Bock L, Beckers PJ, Francis NA, Hopstaken RM, Hood K, et al. Enhanced communication skills and C-reactive protein point-of-care testing for respiratory tract infection: 3.5-year follow-up of a cluster randomized trial. Annals of family medicine. 2013; 11: Altiner A, Brockmann S, Sielk M, Wilm S, Wegscheider K, Abholz HH. Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: a cluster-randomized intervention study. J Antimicrob Chemother. 2007; 60: Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ. 2009; 338: b1374. Page 09
10 BREAKPOINT 20 Gulliford MC, Dregan A, Moore MV, Ashworth M, Staa T, McCann G, et al. Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices. BMJ Open. 2014; 4: e Avent ML, Hall L, Davis L, Allen M, Roberts JA, Unwin S, et al. Antimicrobial stewardship activities: a survey of Queensland hospitals. Australian health review : a publication of the Australian Hospital Association. 2014; 38: James RS, McIntosh KA, Luu SB, Cotta MO, Marshall C, Thursky KA, et al. Antimicrobial stewardship in Victorian hospitals: a statewide survey to identify current gaps. The Medical journal of Australia. 2013; 199: Bryant PA, Australasian Stewardship of Antimicrobials in Paediatrics g. Antimicrobial stewardship resources and activities for children in tertiary hospitals in Australasia: a comprehensive survey. Med J Aust. 2015; 202: Hansen MP, Hoffmann TC, McCullough AR, van Driel ML, Del Mar CB. Antibiotic Resistance: What are the Opportunities for Primary Care in Alleviating the Crisis? Frontiers in public health. 2015; 3: 35. Page 10
11 Issue 15 ANTIMICROBIALS 2016 On behalf of the Australian Society for Antimicrobials I would like to invite you to the Society s 17 th Annual Scientific Meeting Antimicrobials 2016 to be held at the Melbourne Convention Exhibition Centre, Melbourne, on Thursday 25 th - Saturday 27 th February I am pleased to announce Robin Patel, Mayo Clinic, USA; Neil Woodford, Imperial College London, UK; and Chris Baggoley (Chief Medical Officer) and Mark Schipp (Chief Veterinary Officer) will be participating at the meeting. Robin will be presenting the plenary Biofilm Associated Implant Infections, and Neil will be presenting Gram Negative Susceptibility/Resistance Epidemiology. Chris and Mark will be providing an update on the Australian Response to the Antimicrobial Resistance Crisis with particular reference to the recently released The Australian National Antimicrobial Resistance Strategy ( The 2016 Howard Florey Oration will be delivered by Lyn Gilbert from the Institute of Clinical Pathology and Medical Research, New South Wales. Lyn will be presenting the talk Reflections on 50 Years of Antimicrobial Resistance Will Science and Technology or Social Science win the Next 50 Years? The programme s symposia cover many different aspects on antimicrobials and sessions include One Health, Resistant Epidemics - KPCs, ICU Related Infections: Does one Size Fit All?, Infective Endocarditis and Mycobacterium tuberculosis. In addition we have two pharmacy symposia on Saturday afternoon titled Monitoring Outcomes of Antimicrobial Therapy and Using Antimicrobials Better. The scientific symposia it titled Whole Genome Sequencing: Embracing New Technologies. Six proffered papers and two poster sessions are also planned for the meeting. To promote discussion and interaction between delegates and the invited speakers the meeting s registration includes lunches, morning and afternoon teas and admission to the Howard Florey Reception and the Industry Reception. I am confident that you will find the meeting s programme both scientifically stimulating and informative and we look forward to meeting you in Melbourne. The meeting s website, Antimicrobials2016.com, will be available soon IMPORTANT DATES Abstract Submission Deadline Friday 11 th December 2015 Abstract Notification Friday 18 th December 2015 Early Bird Registration Friday 8 th January 2016 Kind regards Thomas Gottlieb President ASA Page 11
12 BREAKPOINT PROPOSED PROGRAM THURSDAY 25 FEBRUARY FRIDAY 26 FEBRUARY SATURDAY 27 FEBRUARY INDUSTRY BREAKFAST SYMPOSIUM Presentation of ASA Awards Thomas Gottlieb ASA President Plenary 1 The Australian Response to the Antimicrobial Resistance Crisis Chris Baggoley, Department of Health, Australian Capital Territory Mark Schipp, Department of Agriculture, Australian Capital Territory Symposium 1 One Health MORNING TEA Salmonella Zoonosis: Epidemiology and Source Tracking Nigel French, Massey University, New Zealand E. coli ST131 Darren Trott, Adelaide University, South Australia Antimicrobial Resistance Surveillance: A Veterinary and Agriculture Perspective David Jordan, Department of Primary Industries, New South Wales Antimicrobial Stewardship: A Veterinary and Agriculture Perspective Glenn Browning, Melbourne University, Victoria PROPOSED INDUSTRY LUNCH SYMPOSIUM Proffered Paper Sessions 1-3 (Three concurrent sessions) INDUSTRY BREAKFAST SYMPOSIUM Plenary 2 Gram Negative Susceptibility/Resistance Epidemiology Neil Woodford, Imperial College London, United Kingdom MORNING TEA Symposium 3 ICU Related Infections: Does one Size fit all? Sepsis Pathway: Have we got it Right and Implications for Antibiotic Use? Simon Finfer, The George Institute for Global Health, New South Wales What is the Role of MRO Screening in the 2016 ICU? Allen Cheng, Alfred Hospital, Victoria Topical Antiseptics in the ICU: Are we Hexed - What is the Role for Antiseptic and Disinfectant Use? Caroline Marshall, Royal Melbourne Hospital, Victoria PROPOSED INDUSTRY LUNCH SYMPOSIUM Proffered Paper Sessions 4-6 (Three concurrent sessions) INDUSTRY BREAKFAST SYMPOSIUM Plenary 3 Biofilm Associated Implant Infections Robin Patel, Mayo Clinic, USA MORNING TEA Symposium 5 Mycobacterium tuberculosis Update on Mtb Treatment Ivan Bastian, SA Pathology, South Australia WGS for Tracking Mtb Transmission Grant Hill-Cawthorne, University of Sydney, New South Wales Susceptibility Testing: Beyond the Dark Ages John Turnidge, Australian Commission on Safety and Quality in Health Care, New South Wales Rapid Diagnostics: Practical Application of Resistance Gene Testing Chris Coulter, Pathology Queensland, Queensland Scientific Symposium I WGS: Embracing New Technologies LUNCH Pharmacy Symposium I Monitoring Outcomes of Antimicrobial Therapy AFTERNOON TEA POSTER SESSION 1 (AUTHORS IN ATTENDANCE) Symposium 2 Resistant Epidemics - KPCs Killer KPCs Worldwide Neil Woodford, Imperial College London, United Kingdom Victorian KPC Experience Jason Kwong, MDU, Doherty Institute, Victoria A Coordinated National Response Mike Richards, The Royal Melbourne Hospital, Victoria Howard Florey Oration Reflections on 50 Years of Antimicrobial Resistance Will Science and Technology or Social Science win the next 50 Years? Gwendolyn Gilbert, Institute of Clinical Pathology and Medical Research, New South Wales Howard Florey Reception AFTERNOON TEA POSTER SESSION 2 (AUTHORS IN ATTENDANCE) Symposium 4 Infective Endocarditis Laboratory Diagnosis Robin Patel, Mayo Clinic, USA Streptococcal/Enterocccal Infective Endocarditis Eugene Athan, Melbourne University, Victoria Is there a Role for TDM in Endocarditis? Jason Roberts, University of Queensland, Queensland Annual General Meeting Industry Reception Current and Future WGS Platforms for the Diagnostic Laboratory Robin Patel, Mayo Clinic, USA Bioinformatic Tools for the Diagnostic Laboratory Torsten Seemann, MDU, Doherty Institute, Victoria Scientific Symposium II WGS: Embracing New Technologies cont. Phenotype from Genotype Neil Woodford, Imperial College London, United Kingdom Using Genomics to Understand Resistance Ben Howden, MDU, Doherty Institute, Victoria Infection Biomarkers: Predictors of Clinical Response Pat Charles, Austin Health, Victoria Using the MIC in Predicting Clinical Outcomes of Antibiotic Treatment Jason Roberts, University of Queensland, Queensland AMS Programs: Measuring the Impact on Patient Care Matthew Rawlins, Fiona Stanley Hospital, Western Australia AFTERNOON TEA Pharmacy Symposium II Using Antimicrobials Better The National Antimicrobial Prescribing Survey: Are we Getting Better? Karin Thursky, Melbourne University, Victoria The Role of the Laboratory: Lessons from AMS Sue Benson, PathWest Laboratory Medicine-WA, Western Australia Hepatitis C: Changing Paradigm of Use of Direct Acting Antivirals Joseph Torresi, Melbourne University, Victoria Page 12
13 Issue MEETING CALENDAR 2016 ESCMID postgraduate course: diagnosis and management of Drug-resistant TB January, Cape town, RSA Website: ASA Annual Meeting February, Melbourne Website: Pathology Update February, Melbourne Website: 17th International Congress of Infectious Diseases 2-5 March, Hyderabad, India Website: 11th International Meeting on Microbial epidemiological markers (postgraduate course) 9-12 March, Estoril,Portugal Website: British Society for Microbiology Annual Meeting March, Liverpool, UK Website: Population modeling and dose optimization with Pmetrics and BestDose: antimicrobial approaches April, Lyons, France Webiste: ASID April, Launceston, Tasmania Website: 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2015) 9-12 April 2016, Amsterdam, The Netherlands Website: American Transplant Congress (ATS congress) June, Boston, MA Website: In 2016, the ASM general meeting and ICAAC will be co-located in Boston, June New * ASM Microbe 2016 (Inaugural combined ASM general meeting with ICAAC) June 2016, Boston, MA Website: Virulence and Resistance in Staphylococcus aureus: 2016 State of the Art, ESCMID Postgraduate Education Course 28 June 1 July, Lyons, France Website: ASM conference on sterptococcal genetics July 31-August , Washington DC Website: 21st International AIDS Conference July, Durban, SA Website: ASM conference on sterptococcal genetics July 31-August , Washington DC Website: 10th International Transplant Infectious Diseases Conference Aug 17-19, Hong Kong, China Website: IMED 2016: International Meeting on Emerging Diseases and Surveillance 4-7 November, Vienna, Austria Website: 16th Asia Pacific Conference on Clinical Microbiology and Infection (APCCMI) 30 Nov- 3 Dec, Melbourne, Australia Website: ASA Annual Meeting, in conjunction with the StaphPath Meeting February, TBD Website: 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2017) April 2017, Vienna, Austria Website: Page 13
FROM THE NEWSLETTER EDITOR S DESK
BREAK POINT 2015 - ISSUE 14 FROM THE NEWSLETTER EDITOR S DESK In line with the New Drugs focus of Breakpoint, this issue brings a summary of the pertinent features of Isavuconazole, a recent addition to
More informationAntimicrobial Stewardship in the Outpatient Setting. ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016
Antimicrobial Stewardship in the Outpatient Setting ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016 Abbreviations AMS - Antimicrobial Stewardship Program OP - Outpatient OPS - Outpatient Setting
More informationAustralia s response to the threat of antimicrobial resistance
Australia s response to the threat of antimicrobial resistance Professor Warwick Anderson AM Chief Executive Officer National Health and Medical Research Council Australia s health system Antimicrobial
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required
More informationGeriatric Mental Health Partnership
Geriatric Mental Health Partnership September 8, 2017 First, let s test your knowledge about antibiotics http://www.cdc.gov/getsmart/community/about/quiz.html 2 Get Smart Antibiotics Quiz Antibiotics fight
More information11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationAntimicrobial Resistance and Dentistry. LDC Officials Day 4 December 2015 Susie Sanderson
Antimicrobial Resistance and Dentistry LDC Officials Day 4 December 2015 Susie Sanderson Who am I? Why are we interested in AMR? Where is the leadership? Who is taking action? What is the BDA doing? Is
More informationPosition Statement The Role of the ICP in Antimicrobial Stewardship
Position Statement The Role of the ICP in Antimicrobial Stewardship ACIPC Recommends Infection control practitioners bring specific expertise and should be part of a multidisciplinary antimicrobial stewardship
More informationAntibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE
Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org
More informationWho is the Antimicrobial Steward?
Who is the Antimicrobial Steward? J. Njeri Wainaina, MD FACP Assistant Professor of Medicine Division of Infectious Diseases and Section of Perioperative Medicine Disclosures None 1 Objectives Highlight
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Preventing the Spread of Antibiotic Resistance and Improving Patient Care (Adapted from the Centers for Disease Control and Prevention) What is Stewardship? Antimicrobial stewardship
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationUPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM
UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health
More informationAntimicrobial Stewardship:
Antimicrobial Stewardship: Inpatient and Outpatient Elements Angela Perhac, PharmD afperhac@carilionclinic.org Disclosure I have no relevant finances to disclose. Objectives Review the core elements of
More informationAntimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS
Antimicrobial Stewardship in the Long Term Care and Outpatient Settings Carlos Reyes Sacin, MD, AAHIVS Disclosure Speaker and consultant in HIV medicine for Gilead and Jansen Pharmaceuticals Objectives
More informationThe Use of Procalcitonin to Improve Antibiotic Stewardship
The Use of Procalcitonin to Improve Antibiotic Stewardship Disclosures I have no actual or potential conflict of interest in relation to this presentation. Patrick A. Laird, DNP, RN, ACNP-BC Objectives
More informationThe UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England
The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England Chief Medical Officer - Annual Report 2013 Antimicrobial resistance poses catastrophic
More informationOutpatient Antimicrobial Stewardship. Jeffrey S Gerber, MD, PhD Division of Infectious Diseases The Children s Hospital of Philadelphia
Outpatient Antimicrobial Stewardship Jeffrey S Gerber, MD, PhD Division of Infectious Diseases The Children s Hospital of Philadelphia Overview The case for outpatient antimicrobial stewardship Interventions
More informationMDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC
MDRO s, Stewardship and Beyond Linda R. Greene RN, MPS, CIC linda_greene@urmc.rochester.edu Evolving Threat of Antimicrobial Resistance Why are MDROs important? Limited treatment options Associated with:
More informationANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU
ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU Health and Food Safety John Paget (NIVEL) Dominique Lescure (NIVEL) Ann Versporten (University of Antwerp)
More informationANTIMICROBIAL STEWARDSHIP IN PRIMARY HEALTH CARE WESTERN CAPE GOVERNMENT: HEALTH METRO DISTRICT FINDINGS 6 MONTHS AFTER INITIATION
ANTIMICROBIAL STEWARDSHIP IN PRIMARY HEALTH CARE WESTERN CAPE GOVERNMENT: HEALTH METRO DISTRICT FINDINGS 6 MONTHS AFTER INITIATION 2018 IHI Africa Forum for Quality and Safety in Healthcare Bart Willems,
More informationImplementing Antibiotic Stewardship in Rural and Critical Access Hospitals
National Center for Emerging and Zoonotic Infectious Diseases Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals Denise Cardo, MD Director, Division of Healthcare Quality Promotion,
More informationHealthcare Facilities and Healthcare Professionals. Public
Document Title: DOH Guidelines for Antimicrobial Stewardship Programs Document Ref. Number: DOH/ASP/GL/1.0 Version: 1.0 Approval Date: 13/12/2017 Effective Date: 14/12/2017 Document Owner: Applies to:
More informationThe South African AMR strategy. 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa
The South African AMR strategy 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa Background to AMR 2 What is Antimicrobial stewardship and
More informationBarriers to Intravenous Penicillin Use for Treatment of Nonmeningitis
JCM Accepts, published online ahead of print on 7 July 2010 J. Clin. Microbiol. doi:10.1128/jcm.01012-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationDevelopment and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics
Priority Topic B Diagnostics Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics The overarching goal of this priority topic is to stimulate the design,
More informationJump Starting Antimicrobial Stewardship
Jump Starting Antimicrobial Stewardship Amanda C. Hansen, PharmD Pharmacy Operations Manager Carilion Roanoke Memorial Hospital Roanoke, Virginia March 16, 2011 Objectives Discuss guidelines for developing
More informationLINEE GUIDA: VALORI E LIMITI
Ferrara 28 novembre 2014 LINEE GUIDA: VALORI E LIMITI Pierluigi Viale Clinica di Malattie Infettive Policlinico S. Orsola Malpighi EVIDENCE BIASED GERIATRIC MEDICINE Older patients with comorbid conditions
More informationDoes Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?
Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs? John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control and
More informationJoint Statement on Antimicrobial Resistance
Joint Statement on Antimicrobial Resistance The UK Faculty of Public Health (FPH), the Royal College of Physicians (RCP), the Royal Pharmaceutical Society (RPS), the Royal College of Nursing (RCN) and
More informationTackling the need for new antibacterial drugs
Tackling the need for new antibacterial drugs Wendy Lawson Lead Pharmacist, Infectious Diseases Imperial College Healthcare NHS Trust, London & Antibiotic Action Champion Timeline of Antibiotic Discovery
More informationM.L. Avent* 1,2, E.Waddell 1, K.Daveson 1 and K. Hajkowicz 1 1. Queensland Statewide Antimicrobial Stewardship 2. UQCCR, The University of Queensland
@MinyonAvent #ruralhealthconf M.L. Avent* 1,2, E.Waddell 1, K.Daveson 1 and K. Hajkowicz 1 1. Queensland Statewide Antimicrobial Stewardship 2. UQCCR, The University of Queensland Queensland State- Wide
More information5/15/17. Core Elements of Outpatient Antibiotic Stewardship: Implementing Antibiotic Stewardship Into Your Outpatient Practice.
National Center for Emerging and Zoonotic Infectious Diseases Core Elements of Outpatient Antibiotic Stewardship: Implementing Antibiotic Stewardship Into Your Outpatient Practice Melinda Neuhauser, PharmD,
More informationAntimicrobial Resistance Update for Community Health Services
Antimicrobial Resistance Update for Community Health Services Elizabeth Beech Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England October 2015 elizabeth.beech@nhs.net Superbugs
More information10/9/2017. Evidence-Based Interventions to Reduce Inappropriate Prescription of Antibiotics. Prescribing for Respiratory Tract Infections
Evidence-Based Interventions to Reduce Inappropriate Prescription of Antibiotics Ann Thomas, MD, MPH Oregon Public Health Division Prescribing for Respiratory Tract Infections Antibiotic use is primary
More informationDrive More Efficient Clinical Action by Streamlining the Interpretation of Test Results
White Paper: Templated Report Comments Drive More Efficient Clinical Action by Streamlining the Interpretation of Test Results Background The availability of rapid, multiplexed technologies for the comprehensive
More informationAntimicrobial stewardship: Quick, don t just do something! Stand there!
Antimicrobial stewardship: Quick, don t just do something! Stand there! Stanley I. Martin, MD, FACP, FIDSA Director, Division of Infectious Diseases Director, Antimicrobial Stewardship Program Geisinger
More informationWHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health
New WHO report provides the most comprehensive picture of antibiotic resistance to date, with data from 114 countries 30 APRIL 2014 GENEVA - A new report by WHO its first to look at antimicrobial resistance,
More information8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM
Mary Moore, MS CIC MT (ASCP) Infection Prevention Coordinator Great River Medical Center, West Burlington REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM ABOUT
More informationCommunity-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018
Community-Associated C. difficile Infection: Think Outside the Hospital Maria Bye, MPH Epidemiologist Maria.Bye@state.mn.us 651-201-4085 May 1, 2018 Clostridium difficile Clostridium difficile Clostridium
More informationGUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 4: Antibiotic Resistance Author M.P. Stevens, MD, MPH S. Mehtar, MD R.P. Wenzel, MD, MSc Chapter Editor Michelle Doll, MD, MPH Topic Outline Key Issues
More informationAntibiotic Stewardship and Critical Access Hospitals. Robert White, BA, PT, CPHQ Program Manager TMF Quality Innovation Network
Antibiotic Stewardship and Critical Access Hospitals Robert White, BA, PT, CPHQ Program Manager TMF Quality Innovation Network Antibiotic-Resistant Bacteria A serious threat to public health and the economy
More information3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats
Antibiotics --When Less is More Ralph Gonzales, MD, MSPH Associate Dean, Clinical Innovation School of Medicine VP, Clinical Innovation, UCSF Health Most Urgent Threats Serious Threats Multidrug-Resistant
More informationAppropriate Antimicrobial Use in California: The Path of Least Resistance
Appropriate Antimicrobial Use in California: The Path of Least Resistance BEACON Fall Exchange November 9, 2011 Kavita K. Trivedi, MD Healthcare Associated Infections Program California Department of Public
More informationCITIZENS JURY ON ANTIMICROBIAL STEWARDSHIP PROGRAMME
CITIZENS JURY ON ANTIMICROBIAL STEWARDSHIP commissioned by the All Wales Medicines Strategy Group Tuesday 5 th Friday 8 th July 2016 Cardiff City Hall Cathays Park, Cardiff CF10 3ND PROGRAMME THE QUESTION
More informationAntibiotic resistance and prescribing in Australia: current attitudes and practice of GPs
CSIRO PUBLISHING Healthcare Infection, 2013, 18, 147 151 http://dx.doi.org/10.1071/hi13019 Antibiotic resistance and prescribing in Australia: current attitudes and practice of GPs Rachel Hardy-Holbrook
More informationAntimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD
Antimicrobial Stewardship Programs The Same, but Different Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Objectives: Outline the overall function of an
More information9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS
Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS 1 2 Untoward Effects of Antibiotics Antibiotic resistance Adverse drug events (ADEs) Hypersensitivity/allergy Drug side effects
More informationExecutive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts
Executive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts Investigational Team: Diane Brideau-Laughlin BSc(Pharm),
More informationStratégies et actions au niveau européen et international: populations humaines
Stratégies et actions au niveau européen et international: populations humaines Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
More informationAntibiotic stewardship Implementing Strategies
2 nd Joint Conference on the Antimicrobial Resistance Action Plan (AMRAP) and the Strategy for the Control of Antimicrobial Resistance in Ireland (SARI) 1. Background Antibiotic stewardship Implementing
More informationAntimicrobial Stewardship in the Hospital Setting
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 12 Antimicrobial Stewardship in the Hospital Setting Authors Dan Markley, DO, MPH, Amy L. Pakyz, PharmD, PhD, Michael Stevens, MD, MPH Chapter Editor
More informationChallenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.
Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S. Overview of benchmarking Antibiotic Use Scott Fridkin, MD, Senior Advisor for Antimicrobial
More informationStratégie et action européennes
Résistance aux antibiotiques : une impasse thérapeutique? Implications nationales et internationales Stratégie et action européennes Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial
More informationOverview of C. difficile infections. Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases
Overview of C. difficile infections Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases Conflicts of Interest I have no financial conflicts of interest related to this topic and presentation.
More informationUnderstand the application of Antibiotic Stewardship regulations in LTC. Understand past barriers to antibiotic management concepts
Objectives Understand the application of Antibiotic Stewardship regulations in LTC Understand past barriers to antibiotic management concepts Understand benefits of adoption of antibiotic stewardship regulations
More informationANTIBIOTIC STEWARDSHIP
ANTIBIOTIC STEWARDSHIP S.A. Dehghan Manshadi M.D. Assistant Professor of Infectious Diseases and Tropical Medicine Tehran University of Medical Sciences Issues associated with use of antibiotics were recognized
More informationQuality and Safety Committee
SUMMARY REPORT Quality and Safety Committee ABM University Health Board Meeting On 20 TH OCTOBER 2016 Subject Prepared by Approved & Presented by Purpose Big Fight Campaign AGENDA ITEM: 2.2 Debra Woolley
More informationDefine evidence based practices for selection and duration of antibiotics to treat suspected or confirmed neonatal sepsis
GLOBAL AIM: Antibiotic Stewardship Perinatal Quality Improvement Teams (PQITs) will share strategies and lessons learned to develop potentially better practices and employ QI methodologies to establish
More informationReady to Launch: Antimicrobial Stewardship for All!
Ready to Launch: Antimicrobial Stewardship for All! Lucas Schulz, PharmD, BCPS AQ ID Clinical Coordinator Infectious Diseases PGY2 Infectious Diseases Residency Program Director Disclosures Consultant
More informationModels for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist
Models for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist philip.howard2@nhs.net Twitter: @AntibioticLeeds United Kingdom of England, Scotland, Wales & Northern Ireland
More informationASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies
ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies Theresa Jaso, PharmD, BCPS (AQ-ID) Network Clinical Pharmacy Specialist Infectious Diseases Seton Healthcare Family Ascension
More informationOutpatient Antibiotic Use and Stewardship in Minnesota. Catherine Lexau, PhD, MPH, RN Epidemiologist Principal Emma Leof, MPH CSTE Fellow May 1, 2018
Outpatient Antibiotic Use and Stewardship in Minnesota Catherine Lexau, PhD, MPH, RN Epidemiologist Principal Emma Leof, MPH CSTE Fellow May 1, 2018 Agenda Outpatient Antibiotic Use Summary Measuring Antibiotic
More informationAntibiotic resistance in West Africa
Antibiotic resistance in West Africa Prof. Pierre Tattevin Infectious Diseases and ICU, Pontchaillou University Hospital, Rennes, France International Society of Chemotherapy No conflict of Interest International
More informationAntibiotic stewardship a role for Managed Care. Doug Burgoyne, PharmD. CEO, Veridicus Health
Antibiotic stewardship a role for Managed Care Doug Burgoyne, PharmD CEO, Veridicus Health GRIP: Global Respiratory Infection Partnership Aim: To decrease inappropriate antibiotic use by developing a consistent
More informationPromoting Appropriate Antimicrobial Prescribing in Secondary Care
Promoting Appropriate Antimicrobial Prescribing in Secondary Care Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2015 Introduction Background ESPAUR
More informationAntimicrobial stewardship in managing septic patients
Antimicrobial stewardship in managing septic patients November 11, 2017 Samuel L. Aitken, PharmD, BCPS (AQ-ID) Clinical Pharmacy Specialist, Infectious Diseases slaitken@mdanderson.org Conflict of interest
More informationOptimizing Antimicrobial Stewardship Activities Based on Institutional Resources
Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov
More informationHot Topics in Antimicrobial Stewardship. Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital
Hot Topics in Antimicrobial Stewardship Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital Antimicrobial Stewardship Goals Primary Goal Optimize clinical outcomes
More informationEuropean Antibiotic Awareness Day
Initiating a pan-european health campaign - experiences from setting up the European Antibiotic Awareness Day Dr Ülla-Karin Nurm Head of Public Health Development Section, Public Health Capacity and Communication
More informationTREAT Steward. Antimicrobial Stewardship software with personalized decision support
TREAT Steward TM Antimicrobial Stewardship software with personalized decision support ANTIMICROBIAL STEWARDSHIP - Interdisciplinary actions to improve patient care Quality Assurance The aim of antimicrobial
More informationPreventing and Responding to Antibiotic Resistant Infections in New Hampshire
Preventing and Responding to Antibiotic Resistant Infections in New Hampshire Benjamin P. Chan, MD, MPH NH Dept. of Health & Human Services Division of Public Health Services May 23, 2017 To bring a greater
More informationWhat is an Antibiotic Stewardship Program?
What is an Antibiotic Stewardship Program? Jane Rogers, R.N. Anne Messer, MPH Learning Session #4 August 15, 2017 National Nursing Home Quality Care Collaborative Change Package Change Bundle: To prevent
More informationAntibiotic Stewardship in the Hospital Setting
Antibiotic Stewardship in the Hospital Setting G. Evans, MD FRCPC Medical Director, Infection Prevention & Control Kingston General Hospital & Hotel Dieu Hospital EOPIC September 26, 2012 Stewardship stew-ard-ship
More informationWhat is the problem? Latest data on antibiotic resistance
European Antibiotic Awareness Day 2009 What is the problem? Latest data on antibiotic resistance Zsuzsanna Jakab, ECDC Director Launch Seminar for EAAD Stockholm, 18 November 2009 Fluoroquinolone-resistant
More informationRecommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland
Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the
More informationNewsflash: Hospital Medicine JOHN C. CHRISTENSEN, MD FACP AMERICAN COLLEGE OF PHYSICIANS, UTAH CHAPTER SCIENTIFIC MEETING FEBRUARY 10, 2017
Newsflash: Hospital Medicine JOHN C. CHRISTENSEN, MD FACP AMERICAN COLLEGE OF PHYSICIANS, UTAH CHAPTER SCIENTIFIC MEETING FEBRUARY 10, 2017 Newsflash: Fluoroquinolones Newsflash: Fluoroquinolones Don t
More informationAntimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The
Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr Nils Anders Tegnell, Director, The Public Health Agency of Sweden The Global Challenge Antibiotics
More informationAntimicrobial Stewardship: The South African Perspective
Antimicrobial Stewardship: The South African Perspective Precious Matsoso Director General; National Department of Health; South Africa 13 th November 2015 Why do we need an AMR strategy and implementation
More informationMHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative
MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative Place picture here Nov. 14, 2017 Reminders For best sound quality, dial in at 1-800-791-2345 and enter code 11076 Please use the chat box to ask questions!
More informationGeoffrey Coombs 1, Graeme Nimmo 2, Julie Pearson 1, Samantha Cramer 1 and Keryn Christiansen 1
Community Onset MRSA Infections in Australia: A Tale of Two Clones Geoffrey Coombs 1, Graeme Nimmo 2, Julie Pearson 1, Samantha Cramer 1 and Keryn Christiansen 1 Community Associated MRSA First isolated
More informationCore Elements of Outpatient Antibiotic Stewardship Implementing Antibiotic Stewardship Into Your Outpatient Practice
National Center for Emerging and Zoonotic Infectious Diseases Core Elements of Outpatient Antibiotic Stewardship Implementing Antibiotic Stewardship Into Your Outpatient Practice Katherine Fleming-Dutra,
More informationANTIMICROBIAL STEWARDSHIP IN PRIMARY CARE DR ROSEMARY IKRAM MBBS FRCPA CLINICAL MICROBIOLOGIST
ANTIMICROBIAL STEWARDSHIP IN PRIMARY CARE DR ROSEMARY IKRAM MBBS FRCPA CLINICAL MICROBIOLOGIST CONFLICTS OF INTEREST NONE PRESENTATION OUTLINE. SETTING THE SCENE WORLD AND NEW ZEALAND. BARRIERS TO OVERCOME.
More informationREPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT
1 REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT The Department of Health organised a summit on Antimicrobial Resistance (AMR) the purpose of which was to bring together all stakeholders involved
More informationVaccination as a potential strategy to combat Antimicrobial Resistance in the elderly
Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly Wilbur Chen, MD, MS 22-23 March 2017 WHO meeting on Immunization of the Elderly The Problem Increasing consumption
More informationImproving patient knowledge of antimicrobial resistance and appropriate antibiotic use in a Rutland county acute care center
University of Vermont ScholarWorks @ UVM Family Medicine Clerkship Student Projects College of Medicine 2019 Improving patient knowledge of antimicrobial resistance and appropriate antibiotic use in a
More informationWORLD ANTIBIOTIC AWARENESS WEEK
# AntibioticResistance WORLD ANTIBIOTIC AWARENESS WEEK 14-20 NOVEMBER 2016 2016 CAMPAIGN TOOLKIT TABLE OF CONTENTS Why we need a global campagin... Campagin objectives... Key messages... Calls to action
More informationCollecting and Interpreting Stewardship Data: Breakout Session
Collecting and Interpreting Stewardship Data: Breakout Session Michael S. Calderwood, MD, MPH Regional Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center March 20, 2019 None Disclosures Outline
More informationDr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust
Dr Eleri Davies Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust Antimicrobial stewardship What is it? Why is it important? Treatment and management of catheter-associated
More informationSurveillance of AMR in PHE: a multidisciplinary,
Surveillance of AMR in PHE: a multidisciplinary, integrated approach Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright International
More informationANTIMICROBIAL RESISTANCE THE AUSTRALIAN CONTEXT. Professor Brendan Murphy Australian Government Chief Medical Officer
ANTIMICROBIAL RESISTANCE THE AUSTRALIAN CONTEXT Professor Brendan Murphy Australian Government Chief Medical Officer AMR in Australia Good understanding but to date not much outcome from actions. The AURA
More informationEpidemiology and Economics of Antibiotic Resistance
Epidemiology and Economics of Antibiotic Resistance Eili Y. Klein February 17, 2016 Health Watch USA Meeting I. The burden of antibiotic resistance is a growing global threat, but hard numbers are lacking
More informationSuccess for a MRSA Reduction Program: Role of Surveillance and Testing
Success for a MRSA Reduction Program: Role of Surveillance and Testing Singapore July 13, 2009 Lance R. Peterson, MD Director of Microbiology and Infectious Disease Research Associate Epidemiologist, NorthShore
More informationSEASONAL TRENDS IN ANTIBIOTIC USAGE AMONG PAEDIATRIC OUTPATIENTS
SEASONAL TRENDS IN ANTIBIOTIC USAGE AMONG PAEDIATRIC OUTPATIENTS Edita Alili-Idrizi, Msc Merita Dauti, Msc State University of Tetovo, Faculty of Medicine, Department of Pharmacy, Tetovo, R. of Macedonia
More informationSurgical prophylaxis for Gram +ve & Gram ve infection
Surgical prophylaxis for Gram +ve & Gram ve infection Professor Mark Wilcox Clinical l Director of Microbiology & Pathology Leeds Teaching Hospitals & University of Leeds, UK Heath Protection Agency Surveillance
More informationAntimicrobial Resistance (2013)
Antimicrobial Resistance (2013) In the second half of 2013, the NIHR issued a call for research into the evaluation of public health measures, health care interventions and health services to reduce the
More informationAntibiotic courses and antibiotic conservation, getting the balance right
Antibiotic courses and antibiotic conservation, getting the balance right Prof Martin Llewelyn Brighton and Sussex Medical School Brighton and Sussex University Hospitals NHS Trust The King's Fund: Ideas
More informationThe Rise of Antibiotic Resistance: Is It Too Late?
The Rise of Antibiotic Resistance: Is It Too Late? Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine None DISCLOSURES THE PROBLEM Antibiotic resistance is one of the
More informationMAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges
Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control
More informationAntibiotic resistance: the rise of the superbugs
Antibiotic resistance: the rise of the superbugs Allen Cheng Associate Professor of Infectious Diseases Epidemiology, Alfred Health; Monash University About me Specialist in infectious diseases Head, Infection
More information